These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24580800)

  • 1. The European Union Committee of Experts on Rare Diseases: three productive years at the service of the rare disease community.
    Aymé S; Rodwell C
    Orphanet J Rare Dis; 2014 Feb; 9():30. PubMed ID: 24580800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Centres of Expertise and European Reference Networks: key issues in the field of rare diseases. The EUCERD Recommendations.
    Taruscio D; Gentile AE; Evangelista T; Frazzica RG; Bushby K; Montserrat AM
    Blood Transfus; 2014 Apr; 12 Suppl 3(Suppl 3):s621-5. PubMed ID: 24922304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How the EUCERD Joint Action supported initiatives on Rare Diseases.
    Lynn S; Hedley V; Atalaia A; Evangelista T; Bushby K;
    Eur J Med Genet; 2017 Mar; 60(3):185-189. PubMed ID: 28087401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the usability of EUCERD core indicators for rare diseases.
    Ferrelli RM; De Santis M; Gentile AE; Taruscio D
    Ann Ist Super Sanita; 2015; 51(4):342-5. PubMed ID: 26783222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Creating a European Union framework for actions in the field of rare diseases.
    Moliner AM
    Adv Exp Med Biol; 2010; 686():457-73. PubMed ID: 20824460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The European Union Policy in the Field of Rare Diseases.
    Moliner AM; Waligora J
    Adv Exp Med Biol; 2017; 1031():561-587. PubMed ID: 29214592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National registries of rare diseases in Europe: an overview of the current situation and experiences.
    Taruscio D; Vittozzi L; Choquet R; Heimdal K; Iskrov G; Kodra Y; Landais P; Posada M; Stefanov R; Steinmueller C; Swinnen E; Van Oyen H
    Public Health Genomics; 2015; 18(1):20-5. PubMed ID: 25228300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The European union policy in the field of rare diseases.
    Montserrat Moliner A; Waligóra J
    Public Health Genomics; 2013; 16(6):268-77. PubMed ID: 24503587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Networking for rare diseases: a necessity for Europe.
    Aymé S; Schmidtke J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2007 Dec; 50(12):1477-83. PubMed ID: 18026888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. European recommendations for primary prevention of congenital anomalies: a joined effort of EUROCAT and EUROPLAN projects to facilitate inclusion of this topic in the National Rare Disease Plans.
    Taruscio D; Arriola L; Baldi F; Barisic I; Bermejo-Sánchez E; Bianchi F; Calzolari E; Carbone P; Curran R; Garne E; Gatt M; Latos-Bieleńska A; Khoshnood B; Irgens L; Mantovani A; Martínez-Frías ML; Neville A; Rißmann A; Ruggeri S; Wellesley D; Dolk H
    Public Health Genomics; 2014; 17(2):115-23. PubMed ID: 24714026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale of the rare cancer list: a consensus paper from the Joint Action on Rare Cancers (JARC) of the European Union (EU).
    Casali PG; Trama A
    ESMO Open; 2020 Mar; 5(2):. PubMed ID: 32220947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pooling of manpower and resources through the establishment of European reference networks and rare disease patient registries is a necessary area of collaboration for rare renal disorders.
    Parker S
    Nephrol Dial Transplant; 2014 Sep; 29 Suppl 4():iv9-14. PubMed ID: 25165190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [European Reference Networks : Consequences for healthcare in Germany].
    Graessner H; Schäfer F; Scarpa M; Wagner TOF
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 May; 60(5):537-541. PubMed ID: 28275837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Policies and actions to tackle rare diseases at European level.
    Montserrat A; Taruscio D
    Ann Ist Super Sanita; 2019; 55(3):296-304. PubMed ID: 31553326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hungarian national plan and strategy for rare diseases].
    Kosztolányi G
    Orv Hetil; 2014 Mar; 155(9):325-8. PubMed ID: 24566695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The context for the thematic grouping of rare diseases to facilitate the establishment of European Reference Networks.
    Evangelista T; Hedley V; Atalaia A; Johnson M; Lynn S; Le Cam Y; Bushby K
    Orphanet J Rare Dis; 2016 Feb; 11():17. PubMed ID: 26911987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tackling rare diseases at European level: why do we need a harmonized framework?
    Taruscio D; Trama A; Stefanov R
    Folia Med (Plovdiv); 2007; 49(1-2):59-67. PubMed ID: 18018471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European expert network on rare communicable diseases and other rare diseases linked to mobility and globalisation focused on health care provision (EURaDMoG): a feasibility study.
    Requena-Méndez A; Bisoffi Z; Vives-Corrons JL; Gascon J; Plasència A
    Orphanet J Rare Dis; 2020 Oct; 15(1):291. PubMed ID: 33066818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Healthcare networks for people with rare diseases: integrating data and expertise].
    Graessner H; Storf H; Schaefer F
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2022 Nov; 65(11):1164-1169. PubMed ID: 36167994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transposition and implementation of EU rare disease policy in Eastern Europe.
    Pejcic AV; Iskrov G; Raycheva R; Stefanov R; Jakovljevic MM
    Expert Rev Pharmacoecon Outcomes Res; 2017 Dec; 17(6):557-566. PubMed ID: 28975845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.